Supremacie - 13537-261-65 - (Ensulizole, Homosalate, Octinoxate, and Oxybenzone)

Alphabetical Index


Drug Information of Supremacie

Product NDC: 13537-261
Proprietary Name: Supremacie
Non Proprietary Name: Ensulizole, Homosalate, Octinoxate, and Oxybenzone
Active Ingredient(s): .001; .001; .00375; .002    g/5g; g/5g; g/5g; g/5g & nbsp;   Ensulizole, Homosalate, Octinoxate, and Oxybenzone
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of Supremacie

Product NDC: 13537-261
Labeler Name: Ventura Corporation, LTDA
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20100219

Package Information of Supremacie

Package NDC: 13537-261-65
Package Description: 1 JAR in 1 JAR (13537-261-65) > 50 g in 1 JAR (13537-261-62)

NDC Information of Supremacie

NDC Code 13537-261-65
Proprietary Name Supremacie
Package Description 1 JAR in 1 JAR (13537-261-65) > 50 g in 1 JAR (13537-261-62)
Product NDC 13537-261
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Ensulizole, Homosalate, Octinoxate, and Oxybenzone
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20100219
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Ventura Corporation, LTDA
Substance Name ENSULIZOLE; HOMOSALATE; OCTINOXATE; OXYBENZONE
Strength Number .001; .001; .00375; .002
Strength Unit g/5g; g/5g; g/5g; g/5g
Pharmaceutical Classes

Complete Information of Supremacie


General Information